| 1. |
Zhao PP, Zhang Y, Gao L, et al. Assessing the clinical features of LGI1 antibody encephalitis. Acta Neurol Belg, 2016, 116(1): 109-112.
|
| 2. |
Schwartz BS, Stewart WF, Simon D, et al. Epidemiology of tension-type headache. JAMA, 1998, 279(5): 381-383.
|
| 3. |
Bigal ME, Bordini CA, Speciali JG. Etiology and distribution of headaches in two Brazilian primary care units. Headache 2000, 40(3): 241-247.
|
| 4. |
唐鶴飛, 劉玉坤, 張然, 等. 富亮氨酸膠質瘤失活 1 蛋白抗體陽性邊緣系統腦炎 7 例臨床分析. 中國神經免疫學和神經病學雜志, 2015, 22(3): 188-190.
|
| 5. |
Bastiaansen AEM, van Sonderen A, Titulaer MJ. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies). Curr Opin Neurol, 2017, 30(3): 302-309.
|
| 6. |
中華醫學會神經病學分會. 中國自身免疫性腦炎診治專家共識. 中華神經科雜志, 2017, 50(2): 91-98.
|
| 7. |
Nosadini M, Mohammad SS, Ramanathan S, et al. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother, 2015, 15(12): 1391-1419.
|